SFTRAK-100/50 DRY SYRUP
About SFTRAK-100/50 DRY SYRUP
SFTRAK-100/50 DRY SYRUP is a pharmaceutical product manufactured and marketed by A3A Pharmaceutical Pvt Ltd, a WHO-GMP compliant company based in Patna, Bihar, India. It contains Cefpodoxime Proxetil 100/50mg, and forms part of our Pediatric range.
Therapeutic segment: Pediatric.
Product information
- Composition
- Cefpodoxime Proxetil 100/50mg
- Uses
- Pediatric bacterial infections
- Recommended dosage
- 5 ml twice daily
Frequently asked questions
What is SFTRAK-100/50 DRY SYRUP?
SFTRAK-100/50 DRY SYRUP is a pharmaceutical product containing Cefpodoxime Proxetil 100/50mg, manufactured and marketed by A3A Pharmaceutical Pvt Ltd, Patna, Bihar, India.
What is SFTRAK-100/50 DRY SYRUP used for?
As per the product information, SFTRAK-100/50 DRY SYRUP is indicated for Pediatric bacterial infections. Use only as directed by a qualified healthcare professional.
What is the composition of SFTRAK-100/50 DRY SYRUP?
SFTRAK-100/50 DRY SYRUP contains Cefpodoxime Proxetil 100/50mg.
What is the recommended dosage of SFTRAK-100/50 DRY SYRUP?
5 ml twice daily Always follow the dosage prescribed by your doctor.
Which therapeutic segment does SFTRAK-100/50 DRY SYRUP belong to?
SFTRAK-100/50 DRY SYRUP is part of the Pediatric range of A3A Pharmaceutical Pvt Ltd.
Who manufactures SFTRAK-100/50 DRY SYRUP?
SFTRAK-100/50 DRY SYRUP is manufactured and marketed by A3A Pharmaceutical Pvt Ltd, a WHO-GMP compliant pharmaceutical company based in Patna, Bihar, India. For distribution, PCD franchise or bulk supply enquiries call +91-83404-30743.
Enquiry
For distribution, PCD franchise or bulk supply enquiries about SFTRAK-100/50 DRY SYRUP, contact A3A Pharmaceutical Pvt Ltd on +91-83404-30743 or email a3apharma@gmail.com.